Adjuvant Holdings Co.,Ltd. (TYO:4929)
Japan flag Japan · Delayed Price · Currency is JPY
794.00
+5.00 (0.63%)
At close: Jan 23, 2026

Adjuvant Holdings Revenue

Adjuvant Holdings had revenue of 1.27B JPY in the quarter ending December 20, 2025, with 8.11% growth. This brings the company's revenue in the last twelve months to 3.97B, down -5.23% year-over-year. In the fiscal year ending March 20, 2025, Adjuvant Holdings had annual revenue of 4.10B, down -7.66%.

Revenue (ttm)
3.97B
Revenue Growth
-5.23%
P/S Ratio
1.60
Revenue / Employee
32.01M
Employees
124
Market Cap
6.35B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 20, 20254.10B-340.00M-7.66%
Mar 20, 20244.44B61.00M1.39%
Mar 20, 20234.38B-50.00M-1.13%
Mar 20, 20224.43B-458.00M-9.38%
Mar 20, 20214.89B211.00M4.51%
Mar 20, 2020 Pro Pro Pro
Mar 20, 2019 Pro Pro Pro
Mar 20, 2018 Pro Pro Pro
Mar 20, 2017 Pro Pro Pro
Mar 20, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Niitaka24.16B
SHOBIDO22.12B
Premier Anti-Aging15.57B
AXXZIA14.03B
Axas Holdings12.45B
HABA Laboratories,Inc.12.16B
Almado9.66B
Liberta9.16B
Revenue Rankings